OpenAI AI Agent Swarm Behind Hugging Face Hack 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Add as a preferred source on Google
SAN FRANCISCO, April 10, 2018 -- Vascular access technology innovator Velano Vascular today announced that company leadership will present at a number of premier healthcare conferences in the second quarter.
Chief Executive Officer Eric M. Stone will moderate a discussion entitled “Innovation and the Four Pillars of Healthcare Progress” at Becker’s Hospital Review 9th Annual Meeting on Thursday, April 12th. Panelists include Patrick Charmel, President and CEO of Griffin Hospital; Kim Henrichsen, RN, MSN, SVP Clinical Operations and Chief Nursing Executive at Intermountain Healthcare; Chris Waugh, Chief Innovation Officer at Sutter Health; and Joan Zoltanski, MD, Chief Experience Officer, University Hospitals Health System.
Stone will also participate in the panel discussion “Strategic Investors Make or Break Us” at HLTH: The Future of Healthcare on Sunday, May 6th in Las Vegas, NV. This conversation will explore the role that strategic investors play in the new healthcare innovation model.
Chief Medical Officer Pitou Devgon, MD will join a panel discussion at The Patient Experience Symposium on Tuesday, May 8th entitled “Engaging Practitioners in Patient Experience Innovation”. Devgon will be joined by Cheryl H. O’Malley DNP, NEA-BC, Vice President, Patient Care Services and Nursing at University Hospitals Cleveland Medical Center.
About Velano Vascular
Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality and needle free blood draws, aiming to deliver painless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com.
Press Contact:
Michael Azzano
Cosmo PR
[email protected]
415-596-1978
